Company: CORT
Filing Date: 2025-11-04
Form Type: 10-Q
Source: 0001628280-25-048841
Chunk: 5

Company: CORCEPT THERAPEUTICS INC
Filing Date: 2025-11-04
Form: 10-Q
Item: Part I, Item 1
Chunk 5
---
705 Issuance of common stock under incentive award plan786 — 3,485 — — — 3,485 Shares tendered to satisfy cost and statutory withholding requirements for net settlement of cashless option exercises and vesting of restricted stock(143)— 2,032 (5,586)— — (3,554)Repurchase of common stock in connection with Stock Repurchase Program(20)— — (476)— — (476)Excise tax related to net share repurchases— — — 81 — — 81 Stock-based compensation— — 12,929 — — — 12,929 Vesting of RSAs in connection with ESPP— — 1,283 — — — 1,283 Other comprehensive loss, net of tax— — — — (351)— (351)Net income— — — — — 27,762 27,762 Balance at March 31, 2024104,028 $133 $758,244 $(641,059)$258 $430,288 $547,864 Issuance of common stock under incentive award plan700 1 7,573 — — — 7,574 Shares tendered to satisfy cost and statutory withholding requirements for net settlement of cashless option exercises and vesting of restricted stock(208)— — (6,242)— — (6,242)Repurchase of common stock in connection with Stock Repurchase Program(122)— — (3,478)— — (3,478)Excise tax related to net share repurchases— — — 16 — — 16 Stock-based compensation— — 13,881 — — — 13,881 Vesting of RSAs in connection with ESPP— — 1,314 — — — 1,314 Other comprehensive loss, net of tax— — — — (174)— (174)Net income— — — — — 35,488 35,488 Balance at June 30, 2024104,398 $134 $781,012 $(650,763)$84 $465,776 $596,243 Issuance of